doctor head
 
  pharmacy and drugs  
search Search
 
       About us       News      A-Z Drugs      Stores      Top Drugs      Contact  
  doctor doctor hand
 
  doctor legs  
 
 
 
 

  Diseases

  Newsletter
Subscribe to our newsletter:
Name:
E-mail:
    Search results
Search results for: ardin

1 - 5 of 44 <<previous | next>>

Drugs results:

Elimite

Elimite

Elimite is the brand name for the medication permethrin a topical cream. Nix Cream Rinse and Acticin are other brand names for this same medication. This drug is a pediculicide and a scabicide, which means it treats lice. A pediculicide is a chemical a more...

Paxil CR

Paxil CR

Paxil CR is the brand name for the medication paroxetine. Other brand name packagings of parozetine are Paxil and Pexeva. This medication is an antidepressant of the group referred to as selective serotonin reuptake inhibitors (SSRIs). Paxil CR impact more...

Wellbutrin SR pills

Wellbutrin SR

Wellbutrin SR is the brand name for the generic drug bupropion. Other brand name packagings for this drug are Zyban SR, Wellbutrin SR XL, and Wellbutrin SR SR. This medication is an antidepressant, used to treat anxiety, seasonal affective disorder and more...

Tamiflu pills

Tamiflu

Tamiflu is the brand name for the generic drug oseltamivir. This drug is used to block the progression of the viruses which cause influenza A and B. This drug is classified as an antiviral medication. Tamiflu, an antiviral medication, needs to be tak more...

Risperidone

Risperidone

Risperidone is an antipsychotic medication. It works by changing the effects of chemicals in the brain. It also used for the treatment of schizophrenia and mania associated with bipolar disorder. It may be used for purposes other than those listed in this more...

Diseases results:

Bacterial infection
Obsessive compulsive disorder
Attention Deficit Disorder
Psychosis
Angina
Insomnia
Alcoholism
Rickets
Gestational diabetes

Articles results:

ABPI Condemns NICE'S Decision On Alzheimer's Medicines, UK
The decision by the National Institute for Clinical and Health Excellence (NICE) to reject appeals against its decision regarding the use of anti-dementia medicines in the treatment of Alzheimer's disease has been condemned by the Association of the British Pharmaceutical Industry (ABPI).


FDA Approves Prescription ZaditorR For Over-The-Counter Relief From Itchy Eyes
Novartis Pharmaceuticals Corporation today announced that the U.S. Food and Drug Administration (FDA) has approved prescription ZaditorĀ® (ketotifen fumarate ophthalmic solution 0.025%), indicated for the temporary prevention of itchy eyes due to allergic conjunctivitis, for OTC use. An estimated 40 million Americans suffer from eye allergies.


Mount Sinai Receives Grant From US Attorney General Office
The Office of the US Attorney General announced today The Mount Sinai Medical Center will be one of five recipients of a prescription drug education grant for health care professionals. The $400,000 grant is funded by the Attorney General Consumer and Prescriber Education Grant Program and will be used to educate physicians and medical students about pharmaceutical company marketing practices and promote evidence-based prescribing practices.


Biotech Industry Welcomes WHO Initiative On Naming Of Biologicals Including Biosimilar Medicines
On Monday 13 November, the Biotech industry will call on the WHO to address the naming (1) of biologicals including biosimilar medicines in the interests of patients and public health at the upcoming meeting for stakeholders organised by the WHO in Geneva (November 13, 2006).EuropaBio welcomes this opportunity by the WHO and the international community to discuss and debate the issues related to the naming of biologicals and biosimilar medicines.


FDA Might Expand Access To Experimental Medications
FDA plans to consider two separate proposals that would expand access to experimental medications for certain patients and allow pharmaceutical companies to charge patients fees for such treatments in some cases, the Wall Street Journal reports. In most cases, patients who seek experimental medications currently must enroll in clinical trials, but patients might not meet requirements for participation.




1 - 5 of 44 <<previous | next>>

© 2006-2010 pharmacy-and-drugs.com. All rights reserved.